
ESSA Pharma Inc (EPIX)
NASDAQ
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.21M | -8.91M | -7.15M | -7.6M | -10.49M | -8.64M | -7.7M | -9.68M |
Pre Tax Income | -7.06M | -7.3M | -5.48M | -5.96M | -8.99M | -7.24M | -6.36M | -8.53M |
Net Income | -7.06M | -7.3M | -5.48M | -5.96M | -8.99M | -7.24M | -6.36M | -8.53M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -8.21M | -8.91M | -7.15M | -7.6M | -10.49M | -8.64M | -7.7M | -9.68M |
EBITDA | -8.21M | -8.91M | -7.03M | -7.57M | -10.47M | -8.62M | -7.67M | -9.66M |
Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -10.87M | -10.8M | -11.26M | -23.52M | -37.14M | -36.96M | -32.13M | -34.42M |
Pre Tax Income | -4.38M | -11.6M | -10.4M | -23.73M | -36.84M | -35.22M | -26.58M | -28.54M |
Net Income | -4.5M | -11.63M | -10.44M | -23.45M | -36.81M | -35.1M | -26.58M | -28.54M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.155 | -2.013 | -0.503 | -0.731 | -0.837 | -0.796 | -0.603 | -0.643 |
EBIT | -10.87M | -10.8M | -8.93M | -23.52M | -37.14M | -36.96M | -32.13M | -34.42M |
EBITDA | -10.82M | -10.77M | -11.24M | -23.52M | -37.14M | -36.96M | -32.02M | -34.33M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.